hepatic impairment
Showing 26 - 50 of 211
Prevention of Thromboembolic Events, Atrial Fibrillation, Acute Myocardial Infarction Trial in Kiel (Asundexian (BAY2433334))
Recruiting
- Prevention of Thromboembolic Events
- +4 more
- Asundexian (BAY2433334)
-
Kiel, Schleswig-Holstein, GermanyCRS-Kiel
Jan 17, 2023
Hepatic Impairment Trial in China (Orelabrutinib Tablets)
Not yet recruiting
- Hepatic Impairment
- Orelabrutinib Tablets
-
Bengbu, Anhui, China
- +4 more
Jan 12, 2023
Hepatic Impairment Trial in Tampa (Fosmanogepix)
Recruiting
- Hepatic Impairment
-
Tampa, FloridaGenesis Clinical Research, LLC
Dec 13, 2022
Healthy, Hepatic Impairment Trial in Porto (Cenerimod)
Recruiting
- Healthy
- Hepatic Impairment
-
Porto, PortugalBlueClinical Phase 1 Hospital de Prelado
Nov 15, 2022
Hepatic Impairment Trial (20 mg HC-ER)
Completed
- Hepatic Impairment
- 20 mg HC-ER
- (no location specified)
Nov 8, 2022
Hepatic Impairment Trial in Chendu (Yimitasvir Phosphate)
Completed
- Hepatic Impairment
- Yimitasvir Phosphate
-
Chendu, Sichuan, ChinaWest China Hospital of Sichuan University
Oct 25, 2022
Hepatic Impairment Trial (oral dose of 200 mg pacritinib twice daily (BID))
Not yet recruiting
- Hepatic Impairment
- oral dose of 200 mg pacritinib twice daily (BID)
- (no location specified)
Sep 23, 2022
Pharmacokinetics, Hepatic Impairment Trial in Knoxville (MDMA)
Not yet recruiting
- Pharmacokinetics
- Hepatic Impairment
-
Knoxville, TennesseeAlliance for Multispecialty Research, LLC.
Aug 17, 2022